Pharmacology, Toxicology and Pharmaceutical Science
6 N,n' Dimethylarginine
9%
Acetylsalicylic Acid
12%
Acute Heart Infarction
14%
Aldosterone
15%
Angiotensin
8%
Angiotensin II
8%
angiotensin[1-7]
9%
Anti-Inflammatory Drug
9%
Blood-Brain Barrier
8%
Cytokine
13%
Depression
25%
Dipeptidyl Carboxypeptidase
8%
Dipeptidyl Carboxypeptidase Inhibitor
29%
Endothelial Dysfunction
8%
Enzyme Inhibition
8%
Erythropoietin
65%
Experimental Myocardial Infarction
9%
Heart Failure
87%
Heart Infarction
100%
Heart Left Ventricle Hypertrophy
11%
Heart Muscle Ischemia
16%
Heart Right Ventricle Hypertrophy
8%
Heart Ventricle Remodeling
9%
Hydrochlorothiazide
20%
Iloprost
8%
Infarction
18%
Inflammation
42%
Ischemia
18%
Lipopolysaccharide
11%
Monocrotaline
12%
Mouse
21%
Munich Wistar Fromter Rat
9%
N(g),n(g) Dimethylarginine
9%
Neovascularization (Pathology)
34%
Nervous System Inflammation
24%
Neutrophil Gelatinase Associated Lipocalin
23%
Nitric Oxide
14%
Pharmacotherapy
12%
Postoperative Cognitive Dysfunction
20%
Pulmonary Hypertension
33%
Quinapril
19%
Rat Model
12%
Recombinant Erythropoietin
10%
Renin
9%
Symptom
16%
Tumor Necrosis Factor
15%
Vascular Remodeling
19%
Vasculotropin
16%
Wistar Rat
12%
Zofenopril
13%
Medicine and Dentistry
ACE Inhibitor
12%
Acetic Acid Derivative
7%
angiotensin[1-7]
8%
Anti-Inflammatory Drug
11%
Arginine
7%
Capillary
11%
Cardiovascular System
22%
Cell Function
10%
Cell Therapy
15%
Cytokine
8%
Depression
24%
Digestive System Surgery
10%
Dipeptidyl Carboxypeptidase
7%
Drug Therapy
18%
Endothelial Dysfunction
12%
Endothelial Function
12%
Endothelial Progenitor Cell
34%
Enzyme Inhibition
7%
Erythropoietin
42%
Experimental Myocardial Infarction
9%
Heart Failure
68%
Heart Function
26%
Heart Left Ventricle Function
9%
Heart Protection
15%
Hematopoiesis
7%
Hypoxia
13%
Infarction
12%
Ischemia
16%
Left Ventricular Hypertrophy
8%
Myocardial Infarction
61%
N(g),n(g) Dimethylarginine
9%
Neuroinflammation
28%
Neutrophil Gelatinase Associated Lipocalin
11%
Nitric Oxide
11%
Pharmacological Target
6%
Positron Emission Tomography
7%
Postoperative Cognitive Dysfunction
27%
Progenitor Cell
16%
Proteinuria
11%
Pulmonary Hypertension
18%
Quinapril
9%
Renin Angiotensin Aldosterone System
8%
SK Channel
6%
Sodium Intake
7%
Sodium Restriction
8%
Spatial Memory
10%
Symptom
10%
Tumor Necrosis Factor
15%
Vascular Remodeling
15%
Vasculotropin
15%
Keyphrases
After Surgery
8%
Age-related
8%
Aged Female Rat
21%
Aged Male Rats
8%
Aged Rats
8%
Angiotensin-converting Enzyme Inhibitor (ACEi)
9%
Animal Research
6%
Animal Use
6%
Anxiety-like Behavior
8%
Behavior Function
7%
Behavioral Effects
7%
Beneficial Effects
19%
Brain Changes
6%
Brain Function
11%
Cardiac Damage
7%
Cardiac Function
8%
Coronary Artery Ligation
8%
Depressive Symptoms
8%
Differential Effects
6%
Erythropoietin
8%
Erythropoietin Analog
7%
Erythropoietin Therapy
7%
Female Rats
9%
Gene Expression Profile
6%
Gut Microbiome
6%
Heart Failure
12%
Heart-brain
7%
Hydrochlorothiazide
13%
Isoproterenol
14%
Isoproterenol-induced Heart Failure
13%
Lipocalin 2 (LCN2)
7%
Male Rats
15%
Microglia
7%
Middle-aged Women
13%
Monocrotaline
9%
Myocardial Infarction
37%
Myocardial Injury
6%
Neuroinflammation
20%
Nitric Oxide Regulation
9%
Postoperative Behavior
9%
Postoperative Cognitive Dysfunction
8%
Pulmonary Arterial Hypertension
6%
Pulmonary Remodeling
6%
Quinapril
17%
Risk Factors
10%
Systemic Inflammation
6%
Treadmill Running
7%
Tumor Necrosis Factor-α
8%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
21%
Whole-body Vibration
20%
